Finally, subcutaneous tumor transplantation experiments were performed, and the results demonstrated that silencing ASAP2 could significantly impair tumor growth in vivo, as evidenced by reduced tumor volumes (Fig. 3L). This evidence concerns the gene ASAP2 and neoplasm.